Toggle navigation
HOME
OPERATIONS MANUAL
CODE OF ETHICS FOR AUTHORS
STATEMENT ON THE USE OF AI
CODE OF CONDUCT FOR REVIEWERS
EDITORIAL POLICIES
BROWSE
CURRENT ISSUE
AHEAD OF PRINT
EDITORIAL BOARD
AUTHORS
INSTRUCTIONS
CONTACT
OPEN ACCESS
Aylin Mora-Seijo
Servicio de OncologÃa ClÃnica, Hospital ClÃnico Quirúrgico Hermanos Ameijeiras, La Habana, Cuba
Nimotuzumab, emergente alternativa inmunoterapéutica en el carcinoma urotelial de vejiga. Reporte de caso
Daniel Carballo-Torres, Iraida Caballero-Aguirrechu, Yunaisi Vassallo-Labrada, Aylin Mora-Seijo
VOLUME 23 - NUMBER 91 /
June
Close
